Intersect Ent Inc 's ability to collect accounts receivable sequentially worsen to 6.82, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Intersect Ent Inc 's Accounts Receivable average collection period in the Mar 31 2022 quarter, has increased to 54 days, from 53 days, in the Dec 31 2021 quarter.

If we take a look into Healthcare sector 282 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2022 from 1800 to 2106.

What is Receivable Turnover Ratio?
What is Intersect Ent Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

XENT Receivables Turnover Ratio	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter
Y / Y Receivable Change	-9.22 %	18.74 %	21.23 %	108.98 %	41.48 %
Y / Y Revenue Change	-11.32 %	8.65 %	7.39 %	179.64 %	22.71 %
Receivable Turnover Ratio (TTM)	6.82	6.85	7	7.2	6.99
XENT's Total Ranking	# 2106	# 1800	# 1919	# 2085	# 1801
Accounts Receivable average collection period days	53	53	52	51	52
Seq. Receivable Change	-23.61 %	20.3 %	-9.95 %	9.68 %	-0.08 %
Seq. Revenue Change	-29.66 %	25.7 %	-10.78 %	12.42 %	-13.82 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 87
Healthcare Sector	# 283
Overall Market	# 2106

Receivable Turnover Ratio Statistics
High	Average	Low
7.34	7	6.69
(Mar 31 2018)		(Dec 31 2019)

XENT Company Profile • Back to XENT Efficiency Comparisons • Compare XENT Receivables Turnover Ratio to its Competitors

Financial Statements
Intersect Ent Inc 's Accounts Receivable	$ 13 Millions	Visit XENT's Balance sheet
Intersect Ent Inc 's Sales TTM	$ 104 Millions	Visit XENT's Income Statement
Sources of XENT's Revenues		Visit XENT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
XENT's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
XENT's Growth Rates	XENT's Roa	XENT's Inventory Turnover Ratio	XENT's Dividend Comparisons
XENT's Profitability Ratios	XENT's Roi	XENT's Asset Turnover Ratio	XENT's Dividend Growth
XENT's Valuation Ratios	XENT's Roe	XENT's Financial Strength Ratios	XENT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2022	Receivable at quarter ending Mar 31 2022
Scorpius Holdings inc	21.03	$ 1.787 Millions	$ 0.085 Millions
Catalyst Pharmaceuticals Inc	20.44	$ 153.717 Millions	$ 7.522 Millions
Theralink Technologies Inc	20.18	$ 0.504 Millions	$ 0.025 Millions
Vtv Therapeutics Inc	19.26	$ 5.018 Millions	$ 0.261 Millions
Innovage Holding Corp	19.20	$ 697.395 Millions	$ 36.326 Millions
Cadre Holdings inc	18.37	$ 421.158 Millions	$ 22.922 Millions
Talphera Inc	18.30	$ 2.749 Millions	$ 0.150 Millions
Intellia Therapeutics Inc	18.21	$ 37.860 Millions	$ 2.079 Millions
Nutriband Inc	17.74	$ 1.467 Millions	$ 0.083 Millions
Immunogen inc	17.73	$ 92.228 Millions	$ 5.201 Millions
Ethema Health Corporation	17.37	$ 2.875 Millions	$ 0.166 Millions
Chemed Corporation	17.36	$ 2,152.820 Millions	$ 124.015 Millions
Denali Therapeutics Inc	17.26	$ 82.879 Millions	$ 4.801 Millions
23andme Holding Co	17.25	$ 271.893 Millions	$ 15.763 Millions
Janux Therapeutics Inc	16.95	$ 1.589 Millions	$ 0.094 Millions
Arbutus Biopharma Corp	16.58	$ 21.456 Millions	$ 1.294 Millions
Jrsis Health Care Corp	16.46	$ 52.684 Millions	$ 3.200 Millions
Electrocore Inc	16.38	$ 6.146 Millions	$ 0.375 Millions
Histogen Inc	16.35	$ 4.356 Millions	$ 0.266 Millions
Travere Therapeutics Inc	16.31	$ 228.570 Millions	$ 14.016 Millions
Neurometrix Inc	16.07	$ 8.400 Millions	$ 0.523 Millions
Chinook Therapeutics Inc	16.01	$ 53.971 Millions	$ 3.371 Millions
Bionexus Gene Lab Corp	15.96	$ 12.942 Millions	$ 0.811 Millions
Reflect Scientific Inc	15.74	$ 3.006 Millions	$ 0.191 Millions
Lftd Partners Inc	15.67	$ 46.393 Millions	$ 2.960 Millions
Apellis Pharmaceuticals Inc	15.66	$ 80.944 Millions	$ 5.169 Millions
Sonendo Inc	15.36	$ 34.803 Millions	$ 2.266 Millions
Sangamo Therapeutics Inc	15.05	$ 112.652 Millions	$ 7.483 Millions
Celldex Therapeutics inc	14.95	$ 4.140 Millions	$ 0.277 Millions
Ainos Inc	14.74	$ 0.680 Millions	$ 0.046 Millions

Date modified: 2026-08-29T17:23:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.